Sepsis: all 1,946 studies

Page 20 of 20. Open to participants first (471), then studies with results posted, then the rest; newest registration first within each.

• Pharmacoeconomic Analysis of First Line Meropenem Versus Standard Antibiotic Treatment in Seriously Infected Secondary Nosocomial Sepsis Syndrome Patients.CompletedNCT00318552Phase 4
• Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic PatientsWithdrawnNCT00304772Phase 4
• Thrombin Generation and Thromboelastography in Non-overt DICTerminatedNCT00299949
• Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?CompletedNCT00284700Not applicable
• BaSES Trial: Basel Starch Evaluation in SepsisCompletedNCT00273728Phase 4
• The Procalcitonin and Survival StudyCompletedNCT00271752Not applicable
• Observational Study of Sepsis and Pneumonia to Develop Diagnostic TestsStatus unknownNCT00258869
• Reconstruction of Monocytic Immunocompetence by Granulocyte-macrophage-colony Stimulating Factor (GM-CSF) in Patients With Severe Sepsis and Septic ShockCompletedNCT00252915Phase 2
• Procalcitonin-Guided Antimicrobial DiscontinuationCompletedNCT00250666Phase 4
• Effect of APC and Epo on the Inflammatory Response During SepsisCompletedNCT00229034
• Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With SepsisCompletedNCT00222222Not applicable
• Selenium, as Sodium Selenite, in the Treatment of Septic ShockCompletedNCT00207844Phase 2
• Botswana Pediatric Respiratory Disease and Bloodstream Infection StudyCompletedNCT00197691
• Treatment Targets for Chronic Hypertension in PregnancyWithdrawnNCT00194974Phase 1/2
• Regulation of Endocrine, Metabolic, Immune and Bioenergetic Responses in SepsisStatus unknownNCT00187824
• Impact of Hydrocortisone Administration on White Blood Cell Gene Expression in Patients With Severe SepsisCompletedNCT00185783
• Predicting Complications in Women With ToxaemiaCompletedNCT00175526
• Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative StaphylococcusCompletedNCT00175370Not applicable
• Near Infrared Spectroscopy (NIRS) in Severe SepsisTerminatedNCT00167596Phase 2/3
• Effect of Hyperglycemia in PAI-1 Activity and the Relationship With Outcome in Severe Sepsis and Septic ShockCompletedNCT00159952Phase 2/3
• A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged LiversCompletedNCT00158769Phase 1
• Norepinephrine Plus Dobutamine Versus Epinephrine Alone for the Management of Septic ShockCompletedNCT00148278Phase 2/3
• Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)CompletedNCT00146432Phase 2/3
• Efficacy & Safety of Resatorvid in Adults With Severe SepsisCompletedNCT00143611Phase 3
• The Benefit of Adding Fish Oil to the Nutrition of Critically Ill PatientsCompletedNCT00142220Phase 4
• Time Course of Procalcitonin and C Reactive Protein in Septic Patients Under Treatment With CorticosteroidsCompletedNCT00141973
• Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell TransplantationCompletedNCT00138112Phase 3
• Prevention of Perinatal Sepsis (PoPS): Evaluation of Chlorhexidine Wipes of Birth Canal and NewbornStatus unknownNCT00136370Phase 3
• Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial)CompletedNCT00135473Phase 3
• Functional Genomic Influences on Disease Progression and Outcome in SepsisStatus unknownNCT00131196
• Chlorhexidine Vaginal and Infant Wash in PakistanCompletedNCT00121394Phase 3
• Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature InfantsCompletedNCT00113191Not applicable
• Unfractioned Heparin for Treatment of SepsisCompletedNCT00100308Phase 3
• A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow TransplantationCompletedNCT00067730Phase 4
• Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream InfectionsStatus unknownNCT00057369Phase 2
• A Trial of Heparin in Patients With Severe Sepsis Who Are Undergoing Treatment With Drotrecogin Alfa (Activated)CompletedNCT00049777Phase 4
• Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe SepsisCompletedNCT00049764Phase 3
• A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe SepsisCompletedNCT00046072Phase 2
• The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe SepsisCompletedNCT00045760Phase 4
• A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and SepsisCompletedNCT00042588Phase 2
• Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe SepsisTerminatedNCT00037687Phase 3
• A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe SepsisCompletedNCT00034476Phase 1/2
• Pleconaril Enteroviral Sepsis SyndromeCompletedNCT00031512Phase 2
• Teicoplanin in Treating Septicemia in Patients Who Are Receiving Chemotherapy Through a Central Venous CatheterStatus unknownNCT00024453Not applicable
• Study of the Relationship Between Feeding and Late Onset Sepsis and/or Necrotizing Enterocolitis in Low Birth Weight InfantsCompletedNCT00005888Not applicable
• Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and SepsisCompletedNCT00004494Phase 1

← Sepsis overview